Apolipoprotein E induces pathogenic senescent-like myeloid cells in prostate cancer
Apolipoprotein E induces pathogenic senescent-like myeloid cells in prostate cancer
复制标题
DOI:
10.1016/j.ccell.2023.02.004
复制
发表时间:
2023-03-13
期刊:
影响因子:
50.3
通讯作者:
Alimonti, Andrea
中科院分区:
文献类型:
--
作者:
Bancaro, Nicolo;Cali, Bianca;Alimonti, Andrea
Tumor cells promote the recruitment of immunosuppressive neutrophils, a subset of myeloid cells driving im-mune suppression, tumor proliferation, and treatment resistance. Physiologically, neutrophils are known to have a short half-life. Here, we report the identification of a subset of neutrophils that have upregulated expression of cellular senescence markers and persist in the tumor microenvironment. Senescent-like neu-trophils express the triggering receptor expressed on myeloid cells 2 (TREM2) and are more immunosuppres-sive and tumor-promoting than canonical immunosuppressive neutrophils. Genetic and pharmacological elimination of senescent-like neutrophils decreases tumor progression in different mouse models of prostate cancer. Mechanistically, we have found that apolipoprotein E (APOE) secreted by prostate tumor cells binds TREM2 on neutrophils, promoting their senescence. APOE and TREM2 expression increases in prostate can-cers and correlates with poor prognosis. Collectively, these results reveal an alternative mechanism of tumor immune evasion and support the development of immune senolytics targeting senescent-like neutrophils for cancer therapy.